Taj Group India
  Quality Medicines Diseases Newsroom Feed back Contactus
  Search
Home
IT Services
Products
Industries
Home >> 
Wipro Infotech
 
Taj Products
Therapeutic Index
Allopathic Products
Injections
Ayurveic & Herbals
Product Index(M.R.P.)
Down Menu

 

 
Taj.Products

rx taj pharma  Taj Brands

Therapeutic Index

    Each Vial 5ml contains:


    Composition:

    Abciximab .....................................................................2 mg


    Indications :

    Platelet aggregation inhibition as adjunct to percutaneous   

    transluminal coronary angioplasty or atherectomy (PTCA).

 

        Description :

    Abciximab (c7E3) is a chimeric mouse-human monoclonal

    antibody directed against the GP IIb/IIIa receptor; its mechanism

    of action is thought to be steric hindrance of the receptor itself as   

    opposed to direct binding to the RGD binding site of the receptor.  

    It also inhibits the vitronectin (av b3)receptor, which mediates

    both platelet coagulation as well as endothelial and vascular  

    smooth muscle cell proliferation.

 

    Dosage: 0.25 mg/kg administered 10-60 minutes before the   

    start of PTCA ` followed by a continuous I.V.. Injection of

    10 mcg/min. for 12 hours.
 

    Presentations:        Vial 5ml                
                                         MRP         Retailer       Stockiest

                                    19740.00    15792.00      14212.80

Structural Formula

 

Taj Values

Tablets

 

 
 

 

Copyright Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap